Telerehabilitation in Central and Peripheral Neurological Sequelae From Chemotherapy

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

August 31, 2026

Conditions
Chemotherapy-induced Neurotoxicity
Interventions
DEVICE

RICORDO-DTx system

Participants with will undergo a cognitive enhancement program using the Astir RICORDO-DTx system (http://www.ricordo-dtx.com), which allows for the personalization of rehabilitative content based on the needs of the target population and can be delivered remotely.

DEVICE

HOMING system

Participants will also undergo motor rehabilitation sessions focused on improving balance, gait, and muscular endurance using the HOMING system (https://www.tecnobody.com/homing).

DEVICE

Home-based training program

Subjects will view videos on Tablet. The treatment will be provided via a digital medicine platform on a mobile device (tablet).

Trial Locations (1)

20148

IRCCS Fondazione Don Carlo Gnocchi ONLUS, Milan

All Listed Sponsors
collaborator

Astir S.r.l.

UNKNOWN

lead

Fondazione Don Carlo Gnocchi Onlus

OTHER

NCT07159854 - Telerehabilitation in Central and Peripheral Neurological Sequelae From Chemotherapy | Biotech Hunter | Biotech Hunter